// App-Quantinova.ai

TCT-837 : Everolimus-eluting versus other rapamycin derivatives-eluting stents in patients with coronary artery disease: a meta-analysis of 16 randomized trials

Researchers

Presenter

  • Yao-Jun Zhang

Principal Investigators

  • Christos Bourantas

  • Shao Liang Chen

  • Javaid Iqbal

  • Takashi Muramatsu

  • Dong Sheng-Jie

  • Bo Xu

Medical Centers

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  • Thoraxcenter, Rotterdam, Netherlands

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing, China

Locations

  • China

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • ZoMaxx

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved